SEC Form D filing

Allinaire Therapeutics Inc., 2026-04-14

An SEC Form D private-offering notice from Cleveland, OH, a $700,000 filer-stated offering target in Biotech. Filed 2026-04-14. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Allinaire Therapeutics Inc. site↗ Verified via SEC Form D

Biotechnology company developing monoclonal antibody therapies for pulmonary arterial hypertension and other lung diseases.

Filed 2026-04-14Filed to raise $700,000First money in 2026-01-30Raised so far $700,000HQ (as filed) Cleveland, OHSector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified allinaire.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source